These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 29427110)
21. Regional and cellular expression of the Machado-Joseph disease gene in brains of normal and affected individuals. Nishiyama K; Murayama S; Goto J; Watanabe M; Hashida H; Katayama S; Nomura Y; Nakamura S; Kanazawa I Ann Neurol; 1996 Nov; 40(5):776-81. PubMed ID: 8957019 [TBL] [Abstract][Full Text] [Related]
22. Machado-Joseph disease enhances genetic fitness: a comparison between affected and unaffected women and between MJD and the general population. Prestes PR; Saraiva-Pereira ML; Silveira I; Sequeiros J; Jardim LB Ann Hum Genet; 2008 Jan; 72(Pt 1):57-64. PubMed ID: 17683516 [TBL] [Abstract][Full Text] [Related]
23. Muscle excitability abnormalities in Machado-Joseph disease. França MC; D'Abreu A; Nucci A; Lopes-Cendes I Arch Neurol; 2008 Apr; 65(4):525-9. PubMed ID: 18413477 [TBL] [Abstract][Full Text] [Related]
26. Normal prion protein in Drosophila enhances the toxicity of pathogenic polyglutamine proteins and alters susceptibility to oxidative and autophagy signaling modulators. Park Y; Kim W; Kim AY; Choi HJ; Choi JK; Park N; Koh EK; Seo J; Koh YH Biochem Biophys Res Commun; 2011 Jan; 404(2):638-45. PubMed ID: 21146501 [TBL] [Abstract][Full Text] [Related]
27. Origins and Spread of Machado-Joseph Disease Ancestral Mutations Events. Martins S; Sequeiros J Adv Exp Med Biol; 2018; 1049():243-254. PubMed ID: 29427107 [TBL] [Abstract][Full Text] [Related]
28. [Somatic mosaicism of expanded CAG trinucleotide repeat in the neural and nonneural tissues of Machado-Joseph disease (MJD)]. Tanaka F; Ito Y; Sobue G Nihon Rinsho; 1999 Apr; 57(4):838-42. PubMed ID: 10222776 [TBL] [Abstract][Full Text] [Related]
29. Defining a metabolic phenotype in the brain of a transgenic mouse model of spinocerebellar ataxia 3. Griffin JL; Cemal CK; Pook MA Physiol Genomics; 2004 Feb; 16(3):334-40. PubMed ID: 14679302 [TBL] [Abstract][Full Text] [Related]
30. A non-radioactive polymerase chain reaction method for diagnosis of Machado-Joseph disease. Hsieh M; Li SY; Chen YY; Tsai CJ; Lin ML; Li C; Wu MJ J Formos Med Assoc; 1999 Oct; 98(10):705-7. PubMed ID: 10575843 [TBL] [Abstract][Full Text] [Related]
31. Machado-Joseph disease: clinical, molecular, and metabolic characterization in Chinese kindreds. Soong B; Cheng C; Liu R; Shan D Ann Neurol; 1997 Apr; 41(4):446-52. PubMed ID: 9124801 [TBL] [Abstract][Full Text] [Related]
32. Involvement of Onuf's nucleus in Machado-Joseph disease: a morphometric and immunohistochemical study. Shimizu H; Yamada M; Toyoshima Y; Ikeuchi T; Onodera O; Takahashi H Acta Neuropathol; 2010 Oct; 120(4):439-48. PubMed ID: 20503052 [TBL] [Abstract][Full Text] [Related]
33. Sleep disorders in Machado-Joseph disease. Pedroso JL; Braga-Neto P; Martinez AR; Martins CR; Rezende Filho FM; Sobreira-Neto MA; Prado LB; do Prado GF; França MC; Barsottini OG Curr Opin Psychiatry; 2016 Nov; 29(6):402-8. PubMed ID: 27584711 [TBL] [Abstract][Full Text] [Related]
34. Intravenous administration of brain-targeted stable nucleic acid lipid particles alleviates Machado-Joseph disease neurological phenotype. Conceição M; Mendonça L; Nóbrega C; Gomes C; Costa P; Hirai H; Moreira JN; Lima MC; Manjunath N; Pereira de Almeida L Biomaterials; 2016 Mar; 82():124-37. PubMed ID: 26757259 [TBL] [Abstract][Full Text] [Related]
35. The genomic structure and expression of MJD, the Machado-Joseph disease gene. Ichikawa Y; Goto J; Hattori M; Toyoda A; Ishii K; Jeong SY; Hashida H; Masuda N; Ogata K; Kasai F; Hirai M; Maciel P; Rouleau GA; Sakaki Y; Kanazawa I J Hum Genet; 2001; 46(7):413-22. PubMed ID: 11450850 [TBL] [Abstract][Full Text] [Related]
37. Epigallocatechin-3-gallate and tetracycline differently affect ataxin-3 fibrillogenesis and reduce toxicity in spinocerebellar ataxia type 3 model. Bonanomi M; Natalello A; Visentin C; Pastori V; Penco A; Cornelli G; Colombo G; Malabarba MG; Doglia SM; Relini A; Regonesi ME; Tortora P Hum Mol Genet; 2014 Dec; 23(24):6542-52. PubMed ID: 25030034 [TBL] [Abstract][Full Text] [Related]
38. Polyglutamine diseases: the special case of ataxin-3 and Machado-Joseph disease. Matos CA; de Macedo-Ribeiro S; Carvalho AL Prog Neurobiol; 2011 Sep; 95(1):26-48. PubMed ID: 21740957 [TBL] [Abstract][Full Text] [Related]
39. Allele-specific RNA silencing of mutant ataxin-3 mediates neuroprotection in a rat model of Machado-Joseph disease. Alves S; Nascimento-Ferreira I; Auregan G; Hassig R; Dufour N; Brouillet E; Pedroso de Lima MC; Hantraye P; Pereira de Almeida L; Déglon N PLoS One; 2008 Oct; 3(10):e3341. PubMed ID: 18841197 [TBL] [Abstract][Full Text] [Related]
40. Beclin 1 mitigates motor and neuropathological deficits in genetic mouse models of Machado-Joseph disease. Nascimento-Ferreira I; Nóbrega C; Vasconcelos-Ferreira A; Onofre I; Albuquerque D; Aveleira C; Hirai H; Déglon N; Pereira de Almeida L Brain; 2013 Jul; 136(Pt 7):2173-88. PubMed ID: 23801739 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]